ArticleEmerging infectious diseases2007
VIM-2-producing Pseudomonas putida, Buenos Aires.
Article in Emerging infectious diseases, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- First Case of VIM-1-like-ProducingAntibiotics (Basel, Switzerland) · 2023Article
- Clinical features, risk factors, and antimicrobial resistance of pseudomonas putida isolates.Medicine · 2022Observational
- Principal component analysis exploring the association between antibiotic resistance and heavy metal tolerance of plasmid-bearing sewage wastewater bacteria of clinical relevance.Access microbiology · 2020Article
- Article
- First Detection of VIM-2 Metallo-β-Lactamase-Producing Pseudomonas putida in Blattella germanica Cockroaches in an Algerian Hospital.Antimicrobial agents and chemotherapy · 2017Article
- Article
- Infections Caused by Antimicrobial Drug-Resistant Saprophytic Gram-Negative Bacteria in the Environment.Frontiers in medicine · 2017Article
- Analysis of the pathogenic potential of nosocomial Pseudomonas putida strains.Frontiers in microbiology · 2015Article
- The complete nucleotide sequence of the carbapenem resistance-conferring conjugative plasmid pLD209 from a Pseudomonas putida clinical strain reveals a chimeric design formed by modules derived from both environmental and clinical bacteria.Antimicrobial agents and chemotherapy · 2014Article
- Nosocomial Pseudomonas putida Bacteremia: High Rates of Carbapenem Resistance and Mortality.Chonnam medical journal · 2012Article
- First report of an extensively drug-resistant VIM-2 metallo-β-lactamase-producing Brevundimonas diminuta clinical isolate.Journal of clinical microbiology · 2012Article
- First case of human infection due to Pseudomonas fulva, an environmental bacterium isolated from cerebrospinal fluid.Journal of clinical microbiology · 2010Article
- KPC-2-producing Enterobacter cloacae and pseudomonas putida coinfection in a liver transplant recipient.Antimicrobial agents and chemotherapy · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.